GENCIRCLE Trademark

Trademark Overview


On Thursday, November 17, 2022, a trademark application was filed for GENCIRCLE with the United States Patent and Trademark Office. The USPTO has given the GENCIRCLE trademark a serial number of 79362417. The federal status of this trademark filing is REGISTERED as of Tuesday, December 5, 2023. This trademark is owned by Nanjing Genscript Biotech Co., Ltd.. The GENCIRCLE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Technology research in the field of gene synthesis; scientific research; research and development of new products for others; scientific laboratory services; biochemical research; chemical analysis; bacteriological research; biological research; medical and scientific research, namely, conducting clinical trials for others; development of pharmaceutical preparations and medicines; biomedical research services; pharmaceutical research services; structural and functional analysis of genomes; medical research; medical laboratory services; stem cell research services; research and development services in the field of antibodies; testing of pharmaceuticals
gencircle

General Information


Serial Number79362417
Word MarkGENCIRCLE
Filing DateThursday, November 17, 2022
Status700 - REGISTERED
Status DateTuesday, December 5, 2023
Registration Number7232801
Registration DateTuesday, December 5, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 19, 2023

Trademark Statements


Pseudo MarkGENE CIRCLE; GENOMES CIRCLE
Goods and ServicesTechnology research in the field of gene synthesis; scientific research; research and development of new products for others; scientific laboratory services; biochemical research; chemical analysis; bacteriological research; biological research; medical and scientific research, namely, conducting clinical trials for others; development of pharmaceutical preparations and medicines; biomedical research services; pharmaceutical research services; structural and functional analysis of genomes; medical research; medical laboratory services; stem cell research services; research and development services in the field of antibodies; testing of pharmaceuticals

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, March 1, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNanjing Genscript Biotech Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCN

Party NameNanjing Genscript Biotech Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCN

Party NameNanjing Genscript Biotech Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCN

Trademark Events


Event DateEvent Description
Monday, January 29, 2024NOTIFICATION PROCESSED BY IB
Tuesday, January 9, 2024FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, January 9, 2024FINAL DISPOSITION PROCESSED
Thursday, January 4, 2024GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, December 5, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, September 19, 2023PUBLISHED FOR OPPOSITION
Monday, September 18, 2023NOTIFICATION PROCESSED BY IB
Wednesday, August 30, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, August 30, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, August 30, 2023NOTICE OF PUBLICATION
Wednesday, August 16, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 15, 2023ASSIGNED TO EXAMINER
Friday, May 12, 2023NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, March 7, 2023APPLICATION FILING RECEIPT MAILED
Wednesday, March 1, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 14, 2023LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, February 9, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB